Patents by Inventor Hylar L. Friedman

Hylar L. Friedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled-release dosage forms of azithromycin
    Patent number: 7108865
    Abstract: A controlled-release dosage form of azithromycin having an improved side effect profile; a process for preparing the dosage form; and a method of treating a microbial infection, comprising administering azithromycin in such a controlled-release dosage form to a mammal, including a human patient, in need of such treatment.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: September 19, 2006
    Assignee: Pfizer Inc
    Inventors: William J. Curatolo, Hylar L. Friedman, Richard W. Korsmeyer, Steven R. LeMott
  • Use of growth hormone secretagogues for stimulating or increasing appetite
    Publication number: 20020086865
    Abstract: This invention is directed to methods for increasing or stimulating appetite in a patient which comprises administering certain growth hormone secretagogues, prodrugs thereof or pharmaceutically acceptable salts of said secretagogues or said prodrugs.
    Type: Application
    Filed: June 27, 2001
    Publication date: July 4, 2002
    Inventors: Hylar L. Friedman, Mark J. Gardner, William H. Landshulz, Lydia C. Pan
  • Controlled- release dosage forms of azithromycin
    Publication number: 20020044965
    Abstract: A controlled-release dosage form of azithromycin having an improved side effect profile; a process for preparing the dosage form; and a method of treating a microbial infection, comprising administering azithromycin in such a controlled-release dosage form to a mammal, including a human patient, in need of such treatment.
    Type: Application
    Filed: March 9, 2001
    Publication date: April 18, 2002
    Inventors: William J. Curatolo, Hylar L. Friedman, Richard W. Koresmeyer, Steven R. LeMott
  • Methods of rapid screening of cytochrome CYP2C19 status using mephenytoin
    Publication number: 20010036440
    Abstract: Mammalian subjects may be phenotyped as poor or extensive metabolizers with respect to CYP2C19 by measuring the ratio of R and S mephenytoin or S-mephenytoin to S-4-hydroxymephenytoin produced from racemic mephenytoin in urine, saliva or plasma samples.
    Type: Application
    Filed: March 26, 2001
    Publication date: November 1, 2001
    Inventors: Hylar L. Friedman, AjitKumar K. Shah
  • Methods of rapid screening of cytochrome CYP2C19 status using omeprazole
    Publication number: 20010036441
    Abstract: Mammalian subjects may be phenotyped with respect to oxidative metabolites involving CYP2C19 by measuring the ratio of omeprazole to its metabolite hydroxyomeprazole in plasma samples.
    Type: Application
    Filed: March 26, 2001
    Publication date: November 1, 2001
    Inventors: Hylar L. Friedman, AjitKumar K. Shah
  • Controlled-release dosage forms of Azithromycin
    Patent number: 6068859
    Abstract: A controlled-release dosage form of azithromycin having an improved side effect profile; a process for preparing the dosage form; and a method of treating a microbial infection, comprising administering azithromycin in such a controlled-release dosage form to a mammal, including a human patient, in need of such treatment.
    Type: Grant
    Filed: November 4, 1996
    Date of Patent: May 30, 2000
    Assignee: Pfizer Inc.
    Inventors: William J. Curatolo, Hylar L. Friedman, Richard W. Korsmeyer, Steven R. LeMott
  • Method of administering azithromycin
    Patent number: 5605889
    Abstract: An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages containing the dosage forms.
    Type: Grant
    Filed: April 29, 1994
    Date of Patent: February 25, 1997
    Assignee: Pfizer Inc.
    Inventors: William J. Curatolo, George H. Foulds, Hylar L. Friedman
  • Method of administering azithromycin
    Patent number: RE39149
    Abstract: An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages containing the dosage forms.
    Type: Grant
    Filed: January 20, 2005
    Date of Patent: June 27, 2006
    Assignee: Pfizer Inc.
    Inventors: William J. Curatolo, George H. Foulds, Hylar L. Friedman